Plunkett Research Online: Erytech Pharma

ERYTECH PHARMA (ERYP:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Erytech Pharma SA is a clinical-stage biopharmaceutical company. It is engaged in conducting activities in research and development in the fields of treatment for acute leukemia and other orphan diseases. The approach by the firm consists of acting on the tumor's environment and starving it so that .....



Erytech Pharma
Ticker: ERYP
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 33 478744438
Fax: 33 478755629
Address: 60 Avenue Rockefeller
Batiment Adenine
Lyon, 69008 France

Map
Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
Contacts Description

Erytech Pharma SA is a clinical-stage biopharmaceutical company. It is engaged in conducting activities in research and development in the fields of treatment for acute leukemia and other orphan diseases. The approach by the firm consists of acting on the tumor's environment and starving it so that .....See More See More

Auditor: KPMG S.A.
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2019 2018 2017 2016 2015 2014
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Name Title Salary (EUR) Bonus (EUR)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: